Tesla vs SpaceX: Which Is the Better Elon Musk-Backed Stock to Buy?

The article favors Tesla over SpaceX, arguing Tesla's robotaxi and Optimus humanoid-robot initiatives are closer to commercialization. Tesla's automotive revenue rose 23% and deliveries increased 25% last quarter, signaling a rebound after pressure from weaker EV demand, lost regulatory-credit revenue, and intensifying competition. SpaceX's cited $1.1 billion-per-month AI compute deal supports faster growth, but the article views that capacity-arbitrage revenue as potentially temporary and expects a future SpaceX acquisition of Tesla.

Analysis

The investable implication is not a binary TSLA-versus-SPCX choice but a valuation-quality divergence: TSLA’s multiple will be governed by evidence that software/services can offset structurally lower automotive unit economics, while SPCX’s implied valuation would be unusually exposed to any normalization in scarce-compute pricing. A compute-arbitrage revenue stream should receive a low multiple until contract duration, power costs, customer concentration, and committed capex are independently disclosed; treating it as recurring cloud revenue risks material downside at the first capacity glut.

For TSLA, the next 1-3 months hinge on whether delivery growth converts into automotive gross-margin stabilization excluding credits and whether paid FSD adoption improves. A successful safety-feature rollout alone is not a robotaxi catalyst: the market needs measurable disengagement, insurance-loss, regulatory-permit, and fleet-utilization data. Without those markers, autonomy and Optimus remain long-duration options that can support sentiment but not near-term earnings estimates.

The non-obvious competitive risk is that a low-cost vision-only architecture only produces superior economics after Tesla clears the safety/regulatory threshold; until then, Waymo’s sensor-heavy model may retain access to higher-value, permitted operating domains. Conversely, confirmed commercial robot deployment would create second-order beneficiaries in actuators, precision gearing, machine vision, and power semiconductors, while pressuring labor-intensive logistics and contract-manufacturing models over 6-18 months. The article’s corporate-combination assertion is speculative and should not be capitalized absent board-level or financing evidence.

Key Decisions for Investors

• Maintain TSLA as a tactical long only against evidence of automotive margin recovery: add after the next earnings release if automotive gross margin ex-credits and FSD-related deferred-revenue recognition both exceed consensus. Target a 10-15% relative move versus QQQ over 1-3 months; exit if deliveries rise but ex-credit gross margin deteriorates, indicating price-led volume rather than earnings repair.
• Do not initiate SPCX exposure solely on the reported compute contract or merger speculation. Create an alert for audited segment disclosure covering contract tenor, customer concentration, incremental power/capex, and cancellation terms; absent this data, downside from a lower revenue-quality multiple likely exceeds upside from headline growth over the next quarter.
• Express a cleaner autonomy upside through a small TSLA call spread rather than outright stock: 6-9 month 10% out-of-the-money call spread, funded only within a defined premium budget. The payoff requires a permit, commercial fleet KPI, or credible monetization disclosure; let the position expire or cut it if no operational catalyst emerges by the following earnings cycle.
• Watch NVDA and broader AI infrastructure for a contrarian read-through: if disclosed compute pricing or utilization weakens, favor an underweight in high-multiple capacity suppliers rather than assuming demand remains structurally supply-constrained. Falsification is continued backlog growth alongside stable pricing and rising utilization through the next two quarterly reports.